 4. Presence of acute active liver disease or acute liver injury as indicated by 1 an abnormal liver function test, or 2 clinical andor laboratory signs of acute, active hepatitis A, B, andor C. Subjects with stable, chronic, active hepatitis B or C may be enrolled if the investigator deems them to be appropriate. 